Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy
Introduction: Huangkui capsule (HKC) is made from the ethanol extract of Abelmoschus manihot (L.) Medik [Malvaceae; abelmoschi corolla] and received approval from the China Food and Drug Administration (Z19990040) in 1999. Currently, HKC is used for treatment of the patients with diabetic nephropath...
Main Authors: | Zhipeng Diao, Hongmei Yu, Yapeng Wu, Yuanbo Sun, Haitao Tang, Mei Wang, Nan Li, Haitao Ge, Jianguo Sun, Harvest F. Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1290868/full |
Similar Items
-
Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of Abelmoschus manihot (L.) Medik. on Renal Fibrosis
by: Gu L, et al.
Published: (2020-10-01) -
AN IN VITRO ANTIOSTEOPOROTIC ACTIVITY OF 96% ETHANOL EXTRACT OF Abelmoschus manihot L. MEDIK LEAVES USING MC3T3-E1 PREOSTEOBLAST CELLS
by: Agnis Pondinekaria Aditama, et al.
Published: (2016-12-01) -
Enrichment and Purification of the Bioactive Flavonoids from Flower of Abelmoschus manihot (L.) Medic Using Macroporous Resins
by: Zhenzhong Yang, et al.
Published: (2018-10-01) -
Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
by: Hongmei Yu, et al.
Published: (2023-08-01) -
Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut–kidney axis
by: Hongmei Yu, et al.
Published: (2024-10-01)